发明名称 NOVEL PYRIMIDINE NUCLEOSIDE COMPOUND OR ITS SALT.
摘要 <p>A novel pyrimidine nucleoside compound, or its salt, of the general formula: (1) wherein one of X and Y is a cyano while the other is a hydrogen atom; and one of R<sup>1</sup> and R<sup>2</sup> is a hydrogen atom, a carbonyl having an alkyl monosubstituted with amino, or a group of the formula (R<sup>3</sup>)(R<sup>4</sup>)(R<sup>5</sup>)Si- while the other is a silyl of the formula (R<sup>6</sup>)(R<sup>7</sup>)(R<sup>8</sup>)Si-, or alternatively R<sup>1</sup> and R<sup>2</sup> together represent a group of the formula -Si(R<sup>9</sup>)(R<sup>10</sup>)- and may form a six-membered cyclic group, provided that each of R<sup>3</sup>, R<sup>4</sup>, R<sup>5</sup>, R<sup>6</sup>, R<sup>7</sup> and R<sup>8</sup> is an alkyl, a cycloalkyl, an aryl or an alkyl substituted with one or two aryls, and that R<sup>9</sup> and R<sup>10</sup> are alkyls. The provided novel pyrimidine nucleoside compounds exhibit antitumor efficacy higher than those of conventional pyrimidine nucleoside compounds.</p>
申请公布号 MX2007009230(A) 申请公布日期 2007.09.19
申请号 MX20070009230 申请日期 2006.01.30
申请人 TAIHO PHARMACEUTICAL CO., LTD. 发明人 NOMURA, MAKOTO;ONO, YAYOI
分类号 C07H19/06;A61K31/7068;A61P35/00;C07F7/10 主分类号 C07H19/06
代理机构 代理人
主权项
地址